Where does Dermapharm AG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Dermapharm AG ranks #46,124 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Dermapharm AG hold?

Dermapharm AG holds 5 US utility patents granted between 2021 and 2023, spanning 2 technology areas.

What is Dermapharm AG's Innovation Score?

Dermapharm AG has an Innovation Score of 23.4 out of 100 (12th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Dermapharm AG's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Dermapharm AG.

What does claim depth mean for Dermapharm AG's patents?

Dermapharm AG's patents average 3.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Dermapharm AG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Dermapharm AG

Q: What technology areas does Dermapharm AG focus on?

Dermapharm AG's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 1 patents. Grants appear in 2 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 2 technology areas, recorded in grant years 2021–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Dermapharm ranks #46,124 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 2 technology areas.

#46,124
of 49,997 US assignees by volume: 12th percentile
by Innovation Score (23.4/100): 3.6
avg claims per patent

USPTO PatentsView assignee plate

Corpus R46124 · Foreign Corporation #46,124 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 5 grants
BOTTOM-DECILE #46,124/49,997
PHOTO-FINISH Densmart Dental
CPC-NARROW A61P · 2 areas
INNOV-THIN 23.4/100
CLAIMS-SPARSE 3.6 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2021–2023 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Densmart Dental Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Sony Media Cloud… · near

23
Casper Sleep · near

23
Chelsea Building… · near

23
USM Holding · near

23
Dermapharm · this assignee

23
3D Lighting… · lowest

7

What this shows Dermapharm's Innovation Score is 23.4/100 (12th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Dermapharm's grants concentrate

Dermapharm AG is a focused PatentsView assignee: 2 CPC subclasses with 20% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2023. By volume, Dermapharm sits between Densmart Dental Co., Ltd. and Devilbiss Healthcare LLC.

Dermapharm's three-year grant acceleration

Dermapharm AG shows 3 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Densmart Dental

5
Denso Aircool

5
Dental Robotics G…

5
Derma Dream Group

5
Desin

5
Deutsches Zentrum…

5
Deuve Photonics

5
Devilbiss Healthc…

5
Dermapharm ◀

5

What this shows Dermapharm holds 5 patents at rank #46,070, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Dermapharm

By rank, the assignees closest to #46,070 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Dermapharm's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Dermapharm, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (23 here).

USM Holding AG 23 Casper Sleep Inc. 23 Chelsea Building Products, Inc. 23 Sony Media Cloud Services LLC 23

Dermapharm's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

23 12th percentile higher than 12% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Dermapharm AG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	2	40.0%
2022	2	40.0%
2023	1	20.0%

Which technologies does Dermapharm AG patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 1

Top 2 of 2 technology areas

Where it ranks

Overall rank by patents

#46,124

of 49,997 tracked assignees

Innovation Score

23.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Dermapharm AG's patent record in context - here's where to go next.

Dermapharm AG's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 20% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #46,124 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Dermapharm AG against Densmart Dental Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 23.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.